Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association

Heidenreich, Paul A., Trogdon, Justin G., Khavjou, Olga A., Butler, Javed, Dracup, Kathleen, Ezekowitz, Michael D., Finkelstein, Eric Andrew, Hong, Yuling +8 more·2011·Circulation

Cited by (1,009)

Items 1,001–1,009 of 1,009

  1. Maternal High Fat Diet and Diabetes Disrupts Transcriptomic Pathways That Regulate Cardiac Metabolism and Cell Fate in Newborn Rat Hearts
    Preston, Claudia C., Larsen, Tricia D., Eclov, Julie A., Louwagie, Eli J., Gandy, Tyler C. T., Faustino, Randolph S., Baack, Michelle L. · 2020 · Frontiers in Endocrinology
  2. Age and Sex Influence Mitochondria and Cardiac Health in Offspring Exposed to Maternal Glucolipotoxicity
    Louwagie, Eli J., Larsen, Tricia D., Wachal, Angela L., Gandy, Tyler C.T., Eclov, Julie A., Rideout, Todd C., Kern, Katherine A., Cain, Jacob T., Anderson, Ruthellen H., Mdaki, Kennedy S. et al. · 2020 · iScience
  3. Serious Adverse Events Experienced by Survivors of Stroke in the First Year Following Discharge from Inpatient Rehabilitation
    Ostwald, Sharon K., Godwin, Kyler M., Ye, Fang, Cron, Stanley G. · 2013 · Rehabilitation Nursing
  4. Geometric anisotropy on biomaterials surface for vascular scaffold design: engineering and biological advances
    Wang, Zuyong, Zhang, Wanqi, Xie, Chao, Wen, Feng, Ma, Chao, Lin, Nan, Thian, Eng San, Wang, Xianwei · 2019 · Journal of Physics: Materials
  5. Interplay of parathyroid hormone and aldosterone antagonist in prevention of heart failure hospitalizations in chronic kidney disease
    Hassan, Mona, Qureshi, Waqas, Sroujieh, Laila S, Albashaireh, Derar, BouMalham, Sara, Liroff, Meghan, Amjad, Waseem, Khalid, Fatima, Hadid, Hiba, Alirhayim, Zaid · 2014 · Journal of the Renin-Angiotensin-Aldosterone System
  6. Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
    Pokharel, Yashashwi, Chinnakondepalli, Khaja, Vilain, Katherine, Wang, Kaijun, Mark, Daniel B., Davies, Glenn, Blazing, Michael A., Giugliano, Robert P., Braunwald, Eugene, Cannon, Christopher P. et al. · 2017 · Circulation: Cardiovascular Quality and Outcomes
  7. A Systematic Review of the Prevalence and Outcomes of Ideal Cardiovascular Health in US and Non-US Populations
    Younus, Adnan, Aneni, Ehimen C., Spatz, Erica S., Osondu, Chukwuemeka U., Roberson, Lara, Ogunmoroti, Oluseye, Malik, Rehan, Ali, Shozab S., Aziz, Muhammad, Feldman, Theodore et al. · 2016 · Mayo Clinic Proceedings
  8. Favorable Cardiovascular Health, Compression of Morbidity, and Healthcare Costs: Forty-Year Follow-Up of the CHA Study (Chicago Heart Association Detection Project in Industry)
    Allen, Norrina B., Zhao, Lihui, Liu, Lei, Daviglus, Martha, Liu, Kiang, Fries, James, Shih, Ya-Chen Tina, Garside, Daniel, Vu, Thanh-Huyen, Stamler, Jeremiah et al. · 2017 · Circulation
  9. Favorable Cardiovascular Health Is Associated With Lower Health Care Expenditures and Resource Utilization in a Large US Employee Population
    Osondu, Chukwuemeka U., Aneni, Ehimen C., Valero-Elizondo, Javier, Salami, Joseph A., Rouseff, Maribeth, Das, Sankalp, Guzman, Henry, Younus, Adnan, Ogunmoroti, Oluseye, Feldman, Theodore et al. · 2017 · Mayo Clinic Proceedings